Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Oncology and cancer conferences
Oncology and Cancer Conferences organised by Allied Academies Conferences is a frontline conference that will identify optimal therapies and address gaps in clinical practices. These Conferences are designed to encourage discussions on innovative treatment, the limitations on existing therapies, and the impact of new research outcomes.
Oncology and Cancer Conferences acts as a platform of knowledge transfer, provides room to debate the existing troubles and an opportunity to network with the masterminds of successful research in the broad fields through keynote lectures, oral and poster presentations, workshops, and exhibitions.
Allied Academies brings translational researchers and clinicians together and builds on an integrated approach for improved patient outcomes. In addition to this great networking opportunity, we are focused on this work to improve the lives of people fighting with cancer around the world.
Oncology and Cancer Conference has gained a paramount significance as the global platform for academicians and industrialists in terms of addressing Cancer, Medical Oncology, Neuro-Oncology, Radiation Oncology, Cancer Proteomics, Diagnostic issues, hematological cancers, International Rare Cancers Initiative, Diagnostic tools and challenges, Regenerative Medicine, Breast cancer, etc.
This global annual conference aims to acknowledge and debate the issues of practitioners for whom the patient cancer journey is important like cancer nurses, general practitioners, oncologists, social workers, psychologist and psychiatrists. We hope to provide an opportunity for practitioners and researchers to share their experiences, and to form collaborations across the local, national and international psycho-oncology community.
Molecular pathology is revolutionising clinical practice in oncology and leads the way for precision medicine. A specialist like molecular pathologists is significant for innovative cancer research and better patient care.
This conference will include a diverse audience including pathologists, molecular pathologists and pathology residents, researchers in the field of molecular diagnostics and precision oncologists. This is done to encourage an interdisciplinary and multidisciplinary approach towards research to aid a better outcome and improved patient care.
Oncology and Cancer Conferences do not only open the gates to the researches and practitioners but also to Industrialist by providing an opportunity to exhibit their innovation and technological marvels. As Industrialist you will have a birds-eye view of how your competitors are positioning themselves in the marketplace, allowing you to effectively evaluate your own position. Beyond being able to deliver your value proposition to prospects face-to-face, exhibiting at Allied Academies conferences also affords you the opportunity to receive real-time feedback on your offering, essentially creating a built-in focus group for your go-to-market strategy.
A conference like this one, simply, does not exist anywhere else in the world, which is one of the very reasons why we have been welcoming hundreds of attendees from all around the globe every year. By addressing clinicians, scientists, industrialists and students as the audience, Allied Academies offers a unique and intimate agenda for networking and exchanges of ideas.
Cancer has become the leading cause of death in the industrialized world and the incidence of cancer is expected to rise by 2.4% annually to reach 14 million per year by 2020 and this urges the increasing demand for cancer studies and cancer drug research. The global cancer drugs market has registered a CAGR of 7.6% from 2018 to 2025, which is accounted for by the rise in the market value of $97,401 million in 2017, to an estimated market value of $176,509 million by 2025.
The major factors that are responsible for the rise in the oncology/cancer drugs market are a surge in cancer research, increased geriatric population, and rise in no. of collaborations between pharmaceutical companies. In addition, a rise in global healthcare expenditure is expected to enhance market expansion.
With the above-mentioned statistics, it is evident that we are at an indispensable need for advancement in cancer research and studies. Researchers around the globe are finding a new advancement each day but that isn`t enough. We at Allied Academies Conferences welcome hundreds of global cancer and healthcare experts to take advantage of this major educational platform to further strengthen the exploration and join hands together to work towards the unique goal of cancer cure.
Every year the Oncology and Cancer Conference offers a selective invitation to the International faculty of unique reports, eminence and expertise, along with few invitations to young researchers to push them into the limelight of the science world and we welcome you to join with us and travel together towards the paramount goal of the fight against cancer.